Latest Insider Transactions at Nuvalent, Inc. (NUVL)
This section provides a real-time view of insider transactions for Nuvalent, Inc. (NUVL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nuvalent, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nuvalent, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 01
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$3,000
$1.08 P/Share
|
|
Jul 31
2023
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-78.3%
|
$1,225,000
$49.05 P/Share
|
|
Jul 31
2023
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$25,000
$1.08 P/Share
|
|
Jul 28
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$312,000
$48.52 P/Share
|
|
Jul 28
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$39,000
$6.89 P/Share
|
|
Jul 28
2023
|
Christopher Durant Turner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,665
-15.51%
|
$127,920
$48.93 P/Share
|
|
Jul 28
2023
|
Christopher Durant Turner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,665
+13.43%
|
$15,990
$6.89 P/Share
|
|
Jul 26
2023
|
Christopher Durant Turner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,365
-14.01%
|
$108,790
$46.85 P/Share
|
|
Jul 26
2023
|
Christopher Durant Turner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,365
+12.29%
|
$14,190
$6.89 P/Share
|
|
Jul 24
2023
|
Christopher Durant Turner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
200
-1.36%
|
$9,200
$46.82 P/Share
|
|
Jul 24
2023
|
Christopher Durant Turner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+1.34%
|
$1,200
$6.89 P/Share
|
|
Jul 20
2023
|
Christopher Durant Turner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
100
-0.68%
|
$4,600
$46.8 P/Share
|
|
Jul 20
2023
|
Christopher Durant Turner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.68%
|
$600
$6.89 P/Share
|
|
Jul 20
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,941
-100.0%
|
$492,345
$45.17 P/Share
|
|
Jul 20
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,941
+50.0%
|
$10,941
$1.08 P/Share
|
|
Jul 19
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,559
-100.0%
|
$205,155
$45.04 P/Share
|
|
Jul 19
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,559
+50.0%
|
$4,559
$1.08 P/Share
|
|
Jul 17
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-63.96%
|
$84,000
$42.74 P/Share
|
|
Jul 17
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$12,000
$6.89 P/Share
|
|
Jul 03
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-90.78%
|
$123,000
$41.73 P/Share
|
|
Jul 03
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$3,000
$1.08 P/Share
|
|
Jun 16
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,900
-100.0%
|
$130,500
$45.19 P/Share
|
|
Jun 16
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,900
+50.0%
|
$2,900
$1.08 P/Share
|
|
Jun 15
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$45,000
$45.07 P/Share
|
|
Jun 15
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$1,000
$1.08 P/Share
|
|
Jun 15
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-66.89%
|
$88,000
$44.05 P/Share
|
|
Jun 15
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$12,000
$6.89 P/Share
|
|
Jun 05
2023
|
Christopher Durant Turner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,235
-41.36%
|
$450,340
$44.86 P/Share
|
|
Jun 05
2023
|
Christopher Durant Turner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,235
+29.26%
|
$61,410
$6.89 P/Share
|
|
Jun 05
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
600
-100.0%
|
$27,000
$45.0 P/Share
|
|
Jun 05
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+50.0%
|
$600
$1.08 P/Share
|
|
Jun 01
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-52.76%
|
$126,000
$42.32 P/Share
|
|
Jun 01
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$3,000
$1.08 P/Share
|
|
May 15
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-62.55%
|
$80,000
$40.6 P/Share
|
|
May 15
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$12,000
$6.89 P/Share
|
|
May 09
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,332
-100.0%
|
$51,948
$39.63 P/Share
|
|
May 09
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,332
+50.0%
|
$7,992
$6.89 P/Share
|
|
May 05
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,800
-100.0%
|
$109,200
$39.64 P/Share
|
|
May 05
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,800
+50.0%
|
$16,800
$6.89 P/Share
|
|
May 01
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-44.18%
|
$111,000
$37.82 P/Share
|
|
May 01
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$3,000
$1.08 P/Share
|
|
May 01
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
900
-100.0%
|
$35,100
$39.61 P/Share
|
|
May 01
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+50.0%
|
$5,400
$6.89 P/Share
|
|
Apr 17
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-53.13%
|
$58,000
$29.74 P/Share
|
|
Apr 17
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$12,000
$6.89 P/Share
|
|
Apr 03
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-98.13%
|
$78,000
$26.82 P/Share
|
|
Apr 03
2023
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$3,000
$1.08 P/Share
|
|
Mar 15
2023
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-95.98%
|
$56,000
$28.7 P/Share
|
|
Mar 15
2023
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$12,000
$6.89 P/Share
|
|
Mar 01
2023
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-93.33%
|
$90,000
$30.08 P/Share
|